Device clinical trial database
This article was originally published in The Gray Sheet
Executive Summary
Health Industry Manufacturers Association requests in a July 14 letter to FDA a 30-day extension of the comment period pertaining to the agency's June 22 notice seeking input on the feasibility of including medical device clinical trials in a public data bank. FDA held a public meeting July 8 to gather input on the issue (1"The Gray Sheet" July 12, p. 27). Because the agency is required by the FDA Modernization Act to submit a recommendation to Congress on the subject by Nov. 21, FDA may hesitate to extend the current Aug. 23 deadline
You may also be interested in...
Public Device Trial Database Raises Confidentiality Concerns - Industry Reps
Inclusion of device clinical trial information in a mandatory, public database could stifle technological innovation in the device industry, trade association reps cautioned at a July 8 public meeting sponsored by FDA.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.